Good analysis Wombat. This co reminds me of Equinox. As one famous guy keeps on saying...let see what happens. Btw, you've left out the "value" of drilled prospects and ground holdings, they're hard to value but i wouldn't be surprised to see them find a string of resources even bigger than Gruyere...at that point, the big fish will eat them.
- Forums
- ASX - By Stock
- GOR
- GOR price target - $1.05 to $1.68 by end 2019
GOR price target - $1.05 to $1.68 by end 2019, page-7
Add GOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.74 |
Change
0.035(2.05%) |
Mkt cap ! $1.787B |
Open | High | Low | Value | Volume |
$1.74 | $1.79 | $1.71 | $13.27M | 7.623M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 89155 | $1.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.74 | 86504 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 34442 | 1.535 |
6 | 76447 | 1.530 |
5 | 125923 | 1.525 |
3 | 36942 | 1.520 |
1 | 4974 | 1.515 |
Price($) | Vol. | No. |
---|---|---|
1.540 | 3247 | 1 |
1.545 | 44647 | 3 |
1.550 | 50856 | 2 |
1.555 | 34988 | 2 |
1.560 | 4974 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
GOR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online